Sort by
Refine Your Search
-
: Design and chemical synthesis of glycopeptide-based probes We are seeking a highly motivated PhD student to join the Bioorganic Synthesis group on a project which aims to develop innovative chemical tools
-
for a PhD candidate. PhD Candidate: Chemical biology of glycopeptide-based probes We are seeking a highly motivated PhD student to join the Bioorganic Synthesis group on a project which aims to develop
-
role in the Netherlands. However, given its environmental impact, the sector must be decarbonised in line with Dutch climate targets. Achieving this requires the development of innovative, transformative
-
economic role in the Netherlands. However, given its environmental impact, the sector must be decarbonised in line with Dutch climate targets. Achieving this requires the development of innovative
-
: Organisational differences (1.0 fte) For our NWO-funded project “From ‘what went wrong’ to ‘what works well?’ Using Safety 2 principles to develop new cybersecurity solutions”, we are looking for a PhD candidate
-
-users and teams (1.0 fte) For our NWO-funded project “From ‘what went wrong’ to ‘what works well?’ Using Safety 2 principles to develop new cybersecurity solutions”, we are looking for a PhD candidate
-
to develop new cybersecurity solutions”, we are looking for a PhD candidate interested in building positive cybersecurity solutions for organisations. In this five-year project, we aim to develop cybersecurity
-
Apply now PhD in organisational cybersecurity: End-users and teams (1.0 fte) For our NWO-funded project “From ‘what went wrong’ to ‘what works well?’ Using Safety 2 principles to develop new
-
interdisciplinary team and explore the complex relationship between behavior and brain health. This project focuses on developing novel measures of brain health by analyzing everyday behavioral patterns. What you
-
on the development of drugs modulating immunometabolism. Immune dysregulation contributes to many human diseases, including cancer, cardiovascular disease, chronic infections, and neurodegeneration. Developing drugs